ACP5 and bone disorder: Estrogen deficiency can also increase the concentration of IL-1, TNF-α [42], and other bone metabolism markers, i.e., bone alkaline phosphatase (bALP) as a marker of bone formation and bone disorders, as well as tartrate-resistant acid phosphatase (TRAP) as a bone resorption marker [43].